http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Deep Learning Model for Smartphone-recorded Cough Sounds: A Prospective Study in Predicting Asthma
( Kyoung Min Moon ),( Hyoungshin Choi ),( Sanghoon Han ),( Jinhee Jeon ),( Choongki Min ),( Kyungnam Kim ),( Donghoon Kim ),( Myung Pyo Kim ),( Young Mi Park ) 대한결핵 및 호흡기학회 2023 대한결핵 및 호흡기학회 추계학술대회 초록집 Vol.136 No.0
( Choongki Kim ),( Hyuk Jae Chang ),( Iksung Cho ),( Ji Min Sung ),( Donghoon Choi ),( Myung Ho Jeong ),( Yang Soo Jang ),( Other Korea Acute Myocardial Infarction Registry Investigato ) 대한내과학회 2013 The Korean Journal of Internal Medicine Vol.28 No.5
Background/Aims: Family history (FHx) of coronary heart disease (CHD) is a well-known risk factor for CHD. However, the prognostic implication of FHx has not been established clearly in patients with acute myocardial infarction (AMI). Methods: In total, 11,612 patients (8,132 males [70%], age 63 ± 13 years) with firstonset AMI between November 2005 and June 2008 in a nationwide, prospective, multicenter, online registry (the Korea AMI Registry) were analyzed. Clinical characteristics and outcomes (cardiac death and major adverse cardiac events [MACEs]) were assessed according to the presence of FHx. Results: The patients with FHx were younger and included more males. Male patients with FHx included more current smokers and individuals with poor lipid profiles. In all patients, after adjustment using the Cox proportional hazard model, FHx was related to the risk of MACEs (hazard ratio [HR], 1.41; p = 0.009) and cardiac death (HR, 1.56; p = 0.080). The poor prognostic implication of FHx was further augmented in females and a low risk subset of patients. A significant interaction was only found between male and female patients for composite MACEs (p for interaction = 0.057), and between patients with more risk factors (≥?2 risk factors) and fewer risk factors for cardiac deaths (p for interaction = 0.008). Conclusions: FHx may be an independent prognostic predictor, especially in female patients and patients with low-risk profile.